drugset / Trial / NCT02663570

Effects of Melatonin in PCOS Women

NCT02663570

NaSingle-groupOpen-labelTreatment

Summary

The aim of our study is to investigate the effects of a treatment with melatonin on clinical, endocrine and metabolic features in women affected by PCOS. The study group included 40 patients treatend with 2 mg of melatonin daily for six months. Menstrual pattern, anthropometric parameters, hirsutism score, ultrasound ovarian volume and antral follicular count, an oral glucose tollerance test and hormonal assays are evaluated before and after therapy.

Timeline

Start
2015-06
Primary completion
2016-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 2 mg